IP Library Granted Patent US 10,759,907
Granted Patent B2
US 10,759,907 · App. 15/758,162 · Granted Sep 1, 2020

Defined monomer sequence polymers

Inventors: Piers Gaffney (London, GB); Andrew Livingston (London, GB); Rongjun Chen (London, GB); Ruijiao Dong (London, GB); Ruiyi Liu (London, GB); Patrizia Marchetti (London, GB)
Assignee: IP2IPO INNOVATIONS LIMITED
C08G65/33396A61K47/60A61K49/0054A61K49/128C08G65/32C08G65/325C08G65/333C08G65/3342C08G65/3344C08G65/3348C08G65/33317
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,759,907
App. No.
15/758,162
Granted
Sep 1, 2020
Kind
B2
Abstract

Processes of preparing defined monomer sequence polymers are disclosed, in which a backbone portion of the polymer is first prepared by performing one or more sequential monomeric coupling reactions with intervening membrane diafiltration purification/isolation steps, followed by a step of decorating the backbone portion with one or more side chains at predetermined positions along its length. The process represents an improvement on prior art techniques, which impose limitations on the size of the side chains that may be present. Defined monomer sequence polymers that are obtainable by the processes are also disclosed.

Claims (24)

1. A process for the preparation of a first compound being a defined monomer sequence polymer, in which at least two of the monomeric units are distinct from each other; the process comprising the steps of:

i) synthesising a backbone portion of the first compound by performing one or more sequential monomeric coupling reactions in a first organic solvent, at least one of the monomeric units used in the sequential monomeric coupling reactions comprising a reactive side chain precursor group, such that the backbone portion comprises one or more reactive side chain precursor groups located at one or more predetermined positions along its length;

ii) between each coupling reaction, separating a product of said one or more sequential coupling reactions from at least one second compound, which is a reaction by-product of the synthesis of the product and/or an excess of a reagent used for the synthesis of the product, and

iii)attaching one or more side chains to the one or more reactive side chain precursor groups located along the length of the backbone portion;

wherein during step (ii) the product of said one or more sequential coupling reactions and at least one second compound are dissolved in a second organic solvent and are separated by a process of diafiltration using a membrane that is stable in the organic solvent and which provides a rejection for the product which is greater than the rejection for the second compound.

2. The process of claim 1 , wherein step (i) comprises synthesising a backbone portion comprising a first reactive side chain precursor group and a second reactive side chain precursor group, and step (iii) comprises attaching a first side chain to the first reactive side chain precursor group and a second side chain to the second reactive side chain precursor group.

3. The process of claim 2 , wherein the first reactive side chain precursor group and the second reactive side chain precursor group are different, and the first side chain and the second side chain are different.

4. The process of claim 3 , wherein a first monomeric unit used in the one or more sequential monomeric coupling reactions comprises the first reactive side chain precursor group and a second monomeric unit used in the one or more sequential monomeric coupling reactions comprises the second reactive side chain precursor group.

5. The process of claim 3 , wherein the first reactive side chain precursor group is configured to react exclusively with the first side chain, and the second reactive side chain precursor group is configured to react exclusively with the second side chain.

6. The process of claim 1 , wherein each side chain independently comprises a group selected from targeting molecules, active pharmaceutical ingredients, imaging agents, sugars, amino acids, peptides, nucleobases, aptamers, oligonucleotides, and monodisperse synthetic polymers.

7. The process of claim 1 , wherein all of the monomeric units used in the one or more sequential monomeric coupling reactions of step (i) have identical backbone moieties.

8. The process of claim 1 , wherein the backbone portion of the first compound is homopolymeric and is selected from poly(ethylene glycol) (PEG), poly(propylene glycol) (PPG), poly(butylene glycol), poly(ethylene oxide), poly(propylene oxide), poly(butylene oxide), poly(dimethylsiloxane) (PDMS), polybutadiene, polyisoprene, polystyrene, nylons and polyesters, poly(ethylene imines) (PEI), poly(propylene imines), poly(L-lysine) (PLL), poly(amidoamines) (PAA), poly(methyl methacrylate) (PMMA), poly(vinyl benzoic acid), poly(hydroxystyrene), N-substituted glycines, and poly(lactide-co-glycolide) (PLGA).

9. The process of claim 1 , wherein the backbone portion of the first compound is a poly(ethylene glycol) homopolymer.

10. The process of claim 1 , wherein not all of the monomeric units used in the one or more sequential monomeric coupling reactions of step (i) have identical backbone moieties.

11. The process of claim 10 , wherein the backbone portion of the first compound is a copolymer formed from two or more of ethylene glycol, propylene glycol, butylene glycol, dimethylsiloxane, butadiene, isoprene, styrene, amides and esters, ethylene imines, propylene imines, L-lysine, amidoamines, methyl methacrylate, vinyl benzoic acid, hydroxystyrene, N-substituted glycines, lactide-co-glycolide, and polymers thereof.

12. The process of claim 1 , wherein during synthesis of the first compound, the product is covalently attached to a synthesis support by an initial monomeric unit.

13. The process of claim 12 , wherein the synthesis support is a branch point molecule having two or more reactive moieties capable of covalently binding to the initial monomeric unit.

14. The process of claim 1 , wherein the one or more reactive side chain precursor groups each comprise a functional group.

15. The process of claim 14 , wherein the functional group is selected from —NH 2 , —C≡C—, —SH, —CO 2 H, —N 3 and —CH═CH 2 .

16. The process of claim 1 , wherein the one or more sequential monomeric coupling reactions each comprise the steps of:

a) reacting a starting material with an excess of an additional monomeric unit, the additional monomeric unit having one of its reactive terminal protected by a protecting group, and

b) removing the protecting group so as to expose the reactive terminal such that it is ready for reaction with a subsequent additional monomeric unit,

wherein the starting material is either an initial monomeric unit having at least one of its reactive terminals protected, or the polymeric product of the one or more sequential monomeric coupling reactions.

17. The process of claim 16 , wherein the step (ii) is performed after step a) and again after step b).

Assignments (2)
CHANGE OF NAME Recorded Jun 19, 2019
From: IMPERIAL INNOVATIONS LIMITED
To: IP2IPO INNOVATIONS LIMITED
Reel/Frame 049524/0147 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2018
From: GAFFNEY, PIERS; LIVINGSTON, ANDREW; CHEN, RONGJUN; DONG, RUIJIAO; LIU, RUIYI; MARCHETTI, PATRIZIA
To: IMPERIAL INNOVATIONS LIMITED
Reel/Frame 046461/0549 →
Priority Claims (1)
GB 1516067.4 · Sep 10, 2015 · national
Continuity (1)
Related Publication 20180244845A1 · Aug 30, 2018